PLoS ONE

Retraction: Improvement of non-invasive tests of liver steatosis and fibrosis as indicators for non-alcoholic fatty liver disease in type 2 diabetes mellitus patients with elevated cardiovascular risk profile using the PPAR-α/γ agonist aleglitazar

View Original
APA MLA Chicago BibTeX RIS

Article Details

Journal PLoS ONE
Volume / Issue Vol. 20, Issue 12
Published December 19, 2025
Pages e0339230
ISSN 1932-6203
Publisher Public Library of Science

Journal Info

PLoS ONE

Public Library of Science
ISSN: 1932-6203 Open Access Health Sciences

Related Articles from this Journal

Promote or prevent? A regulatory focus perspective on managerial risk taking

Amadeusz Jacek Miązek, Justyna Światowiec-Szczepańska Jul 2026 10.1371/journal.pone.0352905

Correction: The spatial spillover effect and its attenuation boundary of urban economy on port efficiency

Deng Zhao, Xu Dongmei et al. Jul 2026 10.1371/journal.pone.0355262

Applications of the Behavior Change Wheel in promoting physical activity among children and adolescents: A scoping review

Zheng Huang, Shuguang Fang et al. Jul 2026 10.1371/journal.pone.0354697

‘Us and them’: A realist interview study exploring how and why health system factors influence dentists’ participation in state funded, contracted primary dental care for low-income populations in Ireland

Paul Leavy, Blánaid Daly et al. Jul 2026 10.1371/journal.pone.0341786

Incremental diagnostic yield of bone scintigraphy after standard radiologic imaging in patients with fall trauma at a Level I trauma center

Su Jin Lee, Young-Sil An et al. Jul 2026 10.1371/journal.pone.0355172